H. Res. 1270 (119th)Bill Overview

Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day".

Simple Resolutiondomestic policy
Cosponsors
Support
Bipartisan
Introduced
May 7, 2026
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Simple ResolutionWhat this resolution actually does

This resolution expresses the House of Representatives support for designating July 15, 2026 as "Glioblastoma Awareness Day" and encourages public awareness, honors patients and caregivers, and supports research efforts. It summarizes facts about glioblastoma and urges collaborative research and investment, including through the Glioblastoma Therapeutics Network. This is a statement of the House's position and does not create law or require action by other branches of government.

Passage rules

As a House simple resolution, it only requires approval by the House of Representatives; it does not go to the Senate or the President and is not legally binding.

This simple House resolution expresses support for designating July 15, 2026, as “Glioblastoma Awareness Day.” It notes glioblastoma incidence, poor survival, high patient costs, the importance of molecular biomarker testing, and encourages awareness, collaboration, and continued research, including support for the Glioblastoma Therapeutics Network.

Passage0/100

This is a nonbinding House simple resolution that does not create law or require enactment; such measures do not become statutes.

CredibilityAligned

Relative to its intended legislative type, this bill is an appropriately constructed commemorative resolution: it clearly defines the public health issue, designates a specific date, and enumerates non‑binding expressions and encouragements to raise awareness and support research.

Contention8/100

Liberals emphasize linking awareness to funding and access

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
WorkersLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitMay increase public awareness and fundraising for glioblastoma research and patient support.
  • Potential benefitEncouraging biomarker testing could improve diagnostic precision and personalized treatment decisions.
  • WorkersSupport for collaborative research and GTN could enhance coordination of trials and translational studies.
Likely burdened
  • Potential burdenThe resolution is symbolic and creates no new funding, entitlements, or legal obligations.
  • Potential burdenMay raise unrealistic expectations about near-term treatment advances without committing resources.
  • Potential burdenGreater emphasis on biomarker testing could increase out-of-pocket expenses for some patients.
03 · Why people split

Why the argument around this bill splits.

Liberals emphasize linking awareness to funding and access
Progressive95%

Likely strongly supportive as a compassionate, research-forward gesture that highlights patient burden and the need for improved treatments.

Would view it as a useful public-awareness tool but incomplete without commitments to funding and access.

Leans supportive
Centrist90%

Generally supportive as a noncontroversial, humanitarian recognition that promotes research collaboration.

Willing to back it while noting the resolution is symbolic and benefits would be greater with measurable follow-up actions.

Leans supportive
Conservative80%

Likely supportive in principle as a tribute to sufferers and families, but inclined to see it as symbolic federal action.

Prefers private charity, state-level efforts, and avoiding new federal spending or mandates.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood0/100

This is a nonbinding House simple resolution that does not create law or require enactment; such measures do not become statutes.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Whether sponsors will seek a companion Senate resolution
  • Whether text will be converted into a concurrent/public law measure
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberals emphasize linking awareness to funding and access

This is a nonbinding House simple resolution that does not create law or require enactment; such measures do not become statutes.

Unlocked analysis

Relative to its intended legislative type, this bill is an appropriately constructed commemorative resolution: it clearly defines the public health issue, designates a specific date, and enumerates non‑binding expressio…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis